Compugen Announces Discovery of Biomarker Candidate for Diagnosis of Ovarian Cancer and Signing of Collaboration Agreement.
Business Wire › February 03, 2009
Linked as:
Extract
Compugen Announces Discovery of Biomarker Candidate for Diagnosis of Ovarian Cancer and Signing of Collaboration Agreement.
Discovery Highlights Compugen's "Discovery on Demand" Capabilities;
Agreement Includes Research Collaboration and Worldwide License Option TEL AVIV, Israel -- Compugen Ltd. (NASDAQ:CGEN) disclosed today the discovery and experimental verification of CGEN-327, a novel molecu...See the full content of this document
Sponsored links
